XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues, net $ 4,977 $ 6,155 $ 14,858 $ 18,557
Cost of revenues 3,181 3,175 9,712 9,591
Gross profit 1,796 2,980 5,146 8,966
Operating expenses        
Sales and marketing 1,660 1,266 5,035 3,780
Research and development 3,034 2,677 8,931 7,743
General and administrative 2,923 2,312 7,937 6,176
Total operating expenses 7,617 6,255 21,903 17,699
Loss from operations (5,821) (3,275) (16,757) (8,733)
Other income, net 190 298 3,889 846
Loss before income taxes (5,631) (2,977) (12,868) (7,887)
Provision for (benefit from) income taxes 105 153 241 (44)
Net loss (5,736) (3,130) (13,109) (7,843)
Foreign currency translation adjustments 42 26 83 (10)
Comprehensive loss $ (5,694) $ (3,104) $ (13,026) $ (7,853)
Net loss per share available to common stockholders, basic (Note 11) $ (0.36) $ (0.22) $ (0.83) $ (0.66)
Net loss per share available to common stockholders, diluted (Note 11) $ (0.36) $ (0.22) $ (0.83) $ (0.66)
Weighted-average shares used to compute net loss per share available to common stockholders, basic 16,030 14,500 15,741 11,956
Weighted-average shares used to compute net loss per share available to common stockholders, diluted 16,030 14,500 15,741 11,956